U.S. cancer doctors to debate care costs

Jun 02, 2006

The American Society of Clinical Oncology's agenda at its Atlanta meeting includes a first time debate on cost-benefit analysis of cancer treatment.

This will be the first time the issue is coming to the fore in the United States where drugs often are allocated based on negotiations between healthcare providers, doctors and insurers, The Financial Times reported.

"In the not-too-distant future, our society will probably be looking more closely at the gains and costs for cancer treatments in the same ways that other therapies have been," Dr. Neal Merosol, the panel's chairman, told the newspaper.

The meeting traditionally has showcased developments in treatment and for marketing new drugs, while the costs of the drugs are not mentioned.

"ASCO needs to take a leadership role in helping to figure out how we can use resources to reward innovation so as to improve cancer treatments, while delivering high-quality care to all patients with cancer. But there is an antagonism between the two," said Merosol.

Copyright 2006 by United Press International

Explore further: Some doctors won't see patients with anti-vaccine views

add to favorites email to friend print save as pdf

Related Stories

'Seeing' hydrogen atoms to unveil enzyme catalysis

Jan 08, 2015

(Phys.org) —Enzymes are catalysts that speed up chemical reactions in living organisms and control many cellular biological processes by converting a molecule, or substrate, into a product used by the cell. ...

Recommended for you

Some doctors won't see patients with anti-vaccine views

just added

With California gripped by a measles outbreak, Dr. Charles Goodman posted a clear notice in his waiting room and on Facebook: His practice will no longer see children whose parents won't get them vaccinated.

Kidney-brain connection may help drive chronic kidney disease

8 minutes ago

In addition to affecting blood pressure, high-salt intake can promote kidney function decline in patients with chronic kidney disease. A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (J ...

Cerebrovascular reserve-based strategy is cost-effective

35 minutes ago

(HealthDay)—A decision rule based on assessment of cerebrovascular reserve (CVR) seems to be cost-effective for prevention of stroke in asymptomatic patients with carotid artery stenosis, according to a ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.